Intuitive Surgical’s Strategic Leadership Transition and DV5 System Launch Support Buy Rating

Wells Fargo analyst Larry Biegelsen has maintained their bullish stance on ISRG stock, giving a Buy rating on May 23.

Larry Biegelsen has given his Buy rating due to a combination of factors including the strategic leadership transition at Intuitive Surgical, which is expected to be seamless as the current CEO transitions to an executive chair role while working closely with the new CEO. This change is not anticipated to alter the company’s strategic direction significantly.
Additionally, the upcoming broad launch of the DV5 system, which has received positive feedback for its integration and efficiency, is another key factor. The system’s features, such as Force Feedback and Case Insights, are expected to enhance the learning curve for surgeons new to robotics. Despite some challenges in the capital equipment environment and potential impacts from tariffs, the company is taking steps to mitigate these risks, which supports the positive outlook.

In another report released on May 23, Citi also maintained a Buy rating on the stock with a $650.00 price target.

ISRG’s price has also changed slightly for the past six months – from $538.550 to $552.410, which is a 2.57% increase.